AGI would produce novel treatments for diseases at rates equivalent to what a human can do today.
Which is to say, not that fast.
Which is to say, not that fast.
It is an open question to what extent practical experimentation/work will be a bottleneck for the theoretical work. It stands to reason that it is improbable that it will be the bottleneck for 100% of the speed of treatment development.